ArticleCancers2022

Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy.

Carolina Mantilla-Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.